Solara Active Pharma's Ambernath Plant Clears USFDA Check

Solara Active Pharma Sciences reported that its Ambernath facility in Maharashtra, having multiple products manufacturing, passed inspection by the United States Food and Drug Administration (USFDA)...

Export Ban to Pakistan Won't Impact Himachal's Pharma Sector

The Centre's latest move to impose a ban on the export of pharmaceuticals to Pakistan, after the April 22 terror attack in Pahalgam, which killed 26 people, will have negligible or no effect on Himachal Pradesh's pharmaceutical industry...

Senores Pharmaceuticals Acquires USFDA-Approved ANDA for Tramadol Tablets

Senores Pharmaceuticals Limited, a world class research based pharmaceutical firm has made a disclosure that its 100% owned subsidiary...

FDC Ltd Recalls Over 60,000 Bottles of Ophthalmic Solution in US

FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...

New Schedule M Requirements Pose Challenge for Drug Manufacturers

According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.

ProBioGen & Polpharma Biologics team up for biosimilar cell lines

Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...

Indian Pharma Faces US Setback Amid Push for Domestic Drug Manufacturing

Indian pharmaceutical companies may encounter significant hurdles in the US following President Donald Trump’s new executive orders aimed at promoting domestic drug production...

The Future of Green Chemistry in API Production

Ashok Kumar, President, Centre for Research and Development at Ipca Laboratories Limited, engages in an exclusive interaction with India Pharma Outlook, wherein he discussed how green chemistry is revolutionizing API production in India. In order to

Indian CDMOs Gain Momentum as Global Pharma Diversifies Away from China

Indian Contract Development and Manufacturing Organisations (CDMOs) like Suven Pharmaceuticals, Syngene International, Laurus Labs, and Divi’s Laboratories are witnessing a surge in demand as global pharma players seek to reduce dependence on...

Strides Strengthens U.S. Market Position with Celecoxib Capsule Approval

The U.S. Food & Drug Administration has approved Celecoxib capsules to market.